Using mobile health apps to improve diabetes management in low-income Hispanic individuals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of mobile health applications in enhancing health outcomes for individuals with type II diabetes within a low-income Hispanic population. Participants will engage in a 6-month program where they will monitor their weight daily and check their blood glucose levels before and after meals. The study focuses on understanding how these digital tools can support better diabetes management and overall health in this demographic. By leveraging technology, the study seeks to address health disparities faced by this community.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with type II diabetes
* Between the age of 18-64
* BMI ≥ 27
* Individual annual income less than $47,520 \[Covered CA income guidelines and salary restrictions\]
* Hispanic and/or Latinx origin
* Monitors blood glucose regularly
* Owns or has access to a bathroom weight scale
* Owns a smartphone and willing to download mobile apps

Exclusion Criteria:

* Does not check blood glucose at least once per day
* On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.

Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are okay

Where it's running

• San Diego State University
  San Diego, California, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

• Clazakizumab for adults with high hsCRP at risk for a heart event

  This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.

  Recruiting at 32 sites Phase 2 Eli Lilly and Company · Huntsville, Alabama and 45 other locations · NCT07783802

• AI-assisted lifestyle plan vs. tirzepatide for obesity with newly diagnosed type 2 diabetes

  This study tests whether an AI-guided lifestyle program can help overweight adults with newly diagnosed type 2 diabetes lose more weight and improve blood sugar control compared with tirzepatide or standard lifestyle care.

  Recruiting at 5 sites Phase 4 The First Affiliated Hospital of Anhui Medical University · Hefei, Anhui and 4 other locations · NCT07697391

• Long-term test of maridebart cafraglutide for obesity and type 2 diabetes

  This extension study tests whether maridebart cafraglutide remains effective and safe for people with obesity and type 2 diabetes who previously completed a parent trial.

  Recruiting at 45 sites Phase 3 Amgen · Gilbert, Arizona and 44 other locations · NCT07684144

• Tirzepatide in real-world Paraguay for obesity and type 2 diabetes

  This study tests tirzepatide in adults in Paraguay to see how it works for weight loss and blood sugar control in everyday clinical practice.

  Recruiting Phase 4 Las Rías Medical Center · Asunción · NCT07588438

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.